When the BIO national convention begins June 15 in Philadelphia, Connecticut will have a conspicuous presence, showcasing several of the bioscience businesses and the support structure that have established the state as a leader in the life sciences area.
At the center of the action will be the Connecticut booth, #4263 located in The Discovery Zone, Hall A-E of the venue, open from 9:30 am Tuesay, June 16, through 4:30 pm Thursday, June 18. (Click here for map.)
In addition, two Connecticut start-ups have been chosen by BIO to present their progress.
One of the companies, LambdaVision, is developing a protein-based retinal implant. Its CEO, Nicole Wagner, was selected as one of Connecticut Magazine’s “Forty Under Forty” earlier this year, and the company was chosen by the National Science Foundation as one of only 35 companies to which it has provided a special kiosk (booth #101) to showcase its technology. View UConn press release re LamdaVision.
The second company, CaroGen Corporation, is an emerging vaccine company with a lead therapeutic program targeting chronic hepatitis B virus (HBV) infection. Its CEO, Bijan Almassian, Ph.D., has been chosen to speak as part of BIO’s “Super Scientist” program. View UConn press release re CaroGen. See also the CI case study re CaroGen.
At the Connecticut booth there will be a daily raffle with exciting prizes. Presenting at the booth during the convention will be the following companies and organizations, among others throughout the week:
Tuesday: LambdaVision, CURE/China Portal, MultiClonal Therapeutics, AlloMek Therapeutics, Lipid Genomics, Aria Neurosciences, BIOARRAY Therapeutics, Arvinas (see the CI case study re Arvinas)
Wednesday: GestVision, HLK Pharma, CaroGen Corporation, Intensity Therapeutics, Vesselon, Mount Sinai Genetics Testing Laboratory, Dura Biotech, Isoplexis
Anchoring the Connecticut booth will be organizations that provide substantial support to biotech start-ups and established life science businesses in the state: the Connecticut Department of Economic and Community Development (DECD); Connecticut Innovations (CI), a leading source of financing for Connecticut’s growing companies; and CURE, the state bioscience association.
In addition, Melinta Therapeutics and law firms Dilworth IP, Shipman & Goodwin and Wiggin and Dana will provide materials to the booth.
Besides DECD, CI, and CURE, sponsors of the Connecticut booth include Yale University, the University of Connecticut, The Jackson Laboratory, Dilworth IP, and the Town of Branford. Sponsors of the specially produced video for the event include Mission Branding, Art of the Cell, and the Angel Investment Forum.